Related Experiment Videos
Evaluating the association between clozapine and venous thromboembolism
1Department of Pharmacy, Saint Joseph HealthCare, Lexington, KY, USA. christopher.paciullo@uky.edu
Summary
Clozapine use is associated with an increased risk of venous thromboembolism (VTE), a serious clotting condition. Patients taking clozapine face a significantly higher mortality rate from VTE compared to the general population.
Area of Science:
- Pharmacology and Toxicology
- Hematology
- Psychiatry
Background:
- Clozapine is an atypical antipsychotic medication used for treatment-resistant schizophrenia.
- Venous thromboembolism (VTE) encompasses deep vein thrombosis and pulmonary embolism, serious conditions with significant morbidity and mortality.
- Previous reports suggest a potential link between clozapine and VTE, necessitating further investigation into the association and underlying mechanisms.
Purpose of the Study:
- To discuss the possible association between clozapine and venous thromboembolism (VTE).
- To review reported cases of VTE in patients treated with clozapine.
- To explore potential mechanisms contributing to clozapine-induced VTE.
Main Methods:
- Review of published case reports detailing VTE occurrences in patients using clozapine.
- Analysis of patient demographics, clinical outcomes, and potential contributing factors from reported cases.
- Examination of the known physiological effects of clozapine relevant to hemostasis and vascular function.
Main Results:
- Twenty-two cases of VTE associated with clozapine have been documented in the literature.
- The average age of affected patients was 38 years, with a reported mortality rate of approximately 44% for clotting complications.
- Clozapine is linked to sedation, weight gain (7-11 kg), and potential coagulation abnormalities, including increased platelet adhesion and aggregation.
Conclusions:
- Available data confirm an association between clozapine and an increased risk of VTE.
- The precise mechanism remains unclear, but multifactorial causes including static blood flow and coagulation abnormalities are implicated.
- The risk-benefit profile of clozapine therapy must be carefully considered, weighing VTE risk against therapeutic benefits.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...